Informed consent is required for New York patients.
5 - 7 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
For more information, please view the literature below.
Procedures for Hemostasis and Thrombosis: A Clinical Test Compendium
Whole blood
1 mL
Lavender-top (EDTA) tube or yellow-top (ACD) tube
Maintain specimen at room temperature. Stable at room temperature or refrigerated for eight days.
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Results of this test are for investigational purposes only. The result should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.
Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) technologies
Deep vein thrombosis (DVT) and coronary artery disease (CAD) are associated with increased PAI-1 levels. Elevated PAI-1 levels may help predict risk of reinfarction in survivors of myocardial infarction, particularly in young individuals. PAI-1 levels tend to be lower in individuals with 4G/5G or 5G/5G genotype compared to a 4G/4G genotype.
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
500309 | PAI-1 Gene Polymorphism | 52757-2 | 500310 | PAI-1 Locus 4G/5G Polymorphism | N/A | |
500309 | PAI-1 Gene Polymorphism | 52757-2 | 500311 | Results | 52757-2 | |
500309 | PAI-1 Gene Polymorphism | 52757-2 | 500312 | Interpretation | N/A | |
500309 | PAI-1 Gene Polymorphism | 52757-2 | 500313 | Comments | 77202-0 |